Advisor Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Advisor Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$837K	Sell	12,925 -1,266	-9%	-$77K	0.01%	1321
2019 Q3	$804K	Buy	14,191 +2,876	+25%	+$165K	0.01%	1285
2019 Q2	$681K	Sell	11,315 -3,840	-25%	-$236K	0.01%	1391
2019 Q1	$988K	Sell	15,155 -765	-5%	-$50.3K	0.01%	1092
2018 Q4	$993K	Sell	15,920 -4,994	-24%	-$337K	0.01%	947
2018 Q3	$1.54M	Sell	20,914 -3,648	-15%	-$262K	0.02%	761
2018 Q2	$1.65M	Sell	24,562 -1,286	-5%	-$82.7K	0.02%	619
2018 Q1	$1.61M	Sell	25,848 -270	-1%	-$17.8K	0.02%	647
2017 Q4	$1.68M	Buy	26,118 +563	+2%	+$36.1K	0.02%	626
2017 Q3	$1.67M	Sell	25,555 -1,429	-5%	-$90.3K	0.03%	573
2017 Q2	$1.69M	Sell	26,984 -10,705	-28%	-$643K	0.03%	538
2017 Q1	$2.21M	Buy	37,689 +6,627	+21%	+$388K	0.04%	427
2016 Q4	$1.74M	Sell	31,062 -9,744	-24%	-$561K	0.04%	471
2016 Q3	$2.52M	Sell	40,806 -13,237	-24%	-$867K	0.06%	340
2016 Q2	$3.42M	Buy	+54,043	New	+$3.4M	0.09%	247

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Advisor Group's PJP Position: Q4 2019 in Review

Advisor Group reduced its Invesco Pharmaceuticals ETF (PJP) stake by 8.9% in Q4 2019, selling an estimated $77K and leaving 12,925 shares worth $837K. The position accounts for 0.01% of the portfolio, ranked #1321.

Advisor Group first reported a position in PJP in Q2 2016 and has held it in 15 quarters since. The position peaked at $3.42M in Q2 2016. 93 funds tracked by Wall St. Rank hold PJP as of Q4 2019.

Advisor Group held 12,925 shares of Invesco Pharmaceuticals ETF worth $837K as of Q4 2019.
Advisor Group sold 1,266 Invesco Pharmaceuticals ETF shares in Q4 2019, an estimated $77K.
Invesco Pharmaceuticals ETF made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1321 holding.
Advisor Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Invesco Pharmaceuticals ETF position peaked at $3.42M in Q2 2016.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.